Wall Street Analysts Think Newmont (NEM) Is a Good Investment: Is It? — Positive
NEM Zacks Investment Research — November 14, 2025Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? — Positive
ADMA Zacks Investment Research — November 14, 2025When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Timken Declares Quarterly Dividend of 35 Cents Per Share — Neutral
TKR PRNewsWire — November 14, 2025NORTH CANTON, Ohio , Nov. 14, 2025 /PRNewswire/ -- The board of directors of The Timken Company (NYSE: TKR; www.timken.com), a global technology leader in engineered bearings and industrial motion, today declared a quarterly cash dividend of 35 cents per share. The dividend is payable on Dec. 5, 2025, to shareholders of record as of Nov. 25, 2025.
Pearl Diver Credit Company: Shares Are A 'Maybe,' Preferreds Are A 'Yes' — Neutral
PDCC PDPA Seeking Alpha — November 14, 2025Pearl Diver Credit Company specializes in CLO equity, but I favor its Series A preferred shares (PDPA) for their superior capital stack position. PDPA offers an 8% cumulative dividend, trades near par, and boasts a strong asset coverage ratio of nearly 400%, enhancing safety. With a mandatory redemption in December 2029 and a yield to maturity around 7.7%, PDPA provides attractive risk-adjusted returns.
Portnoy Law Firm Announces Class Action on Behalf of Fluor Corporation Investors — Neutral
FLR GlobeNewsWire — November 14, 2025LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fluor Corporation, (“Fluor” or the "Company") (NYSE: FLR) investors of a class action on behalf of investors that bought securities between February 18, 2025 and July 31, 2025, inclusive (the “Class Period”). Fluor investors have until November 14, 2025 to file a lead plaintiff motion.
JHX Investors Have Opportunity to Lead James Hardie Industries plc Securities Fraud Lawsuit with the Schall Law Firm — Neutral
JHX GlobeNewsWire — November 14, 2025LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against James Hardie Industries plc (“James Hardie” or “the Company”) (NYSE: JHX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 20, 2025, and August 18, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 23, 2025.
Intuitive Surgical Stock Is Up 31% Since October Lows After Powerful Earnings Turnaround — Positive
ISRG Investors Business Daily — November 14, 2025As the overall market trend weakens, one area that remains intact is medical stocks — namely Intuitive Surgical.
TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX — Neutral
TLX PRNewsWire — November 14, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telix Pharmaceuticals Limited ("Telix" or the …
Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline — Neutral
AUTL Seeking Alpha — November 14, 2025Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline
Wall Street Doubles Down On Nvidia Amid AI Stock Slump — Positive
NVDA Investors Business Daily — November 14, 2025Wall Street analysts are expressing confidence in Nvidia stock to regain its mojo ahead of the AI chip leader's earnings report next week.
Nexstar Media: Market Not Appreciating Its Durability (Upgrade) — Positive
NXST Seeking Alpha — November 14, 2025Nexstar Media: Market Not Appreciating Its Durability (Upgrade)
INSP DEADLINE: Faruqi & Faruqi Reminds Inspire Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 - INSP — Neutral
INSP PRNewsWire — November 14, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. …
Dillard's Q3 Earnings Beat Estimates, Comparable Store Sales Rise 3% — Positive
DDS Zacks Investment Research — November 14, 2025DDS delivers a Q3 beat as sales rise 2.9% and comps climb 3%, sending shares up about 10% on stronger retail momentum.
FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit — Negative
FONR Zacks Investment Research — November 14, 2025FONR reports top-line growth for first-quarter fiscal 2026 amid earnings decline and increased SG&A and operating expenses.
Can Goldman's Expansion in Private Equity Credit Drive Growth? — Positive
GS Zacks Investment Research — November 14, 2025GS ramps up private equity and credit with acquisitions, global expansion and boosted alternatives fundraising goals.
We believe Adobe (ADBE) is starting to screen like a value candidate. The stock now trades nearly 40% below its 12-month high and at a price-to-sales ratio meaningfully below its three-year average — a rare reset for a premium software name.
Robinhood Stock Testing Key Trendline Amid Tech Rotation — Negative
HOOD Schaeffers Research — November 14, 2025Robinhood Markets Inc (NASDAQ:HOOD) stock is struggling amid an extended tech sector rotation , last seen down 0.1% to trade at $121.39.
KBR DEADLINE: Faruqi & Faruqi Reminds KBR Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18, 2025 - KBR — Neutral
KBR PRNewsWire — November 14, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. ("KBR" or the "Company") …
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
BAX GlobeNewsWire — November 14, 2025LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 15, 2025.
Walmart Inc (NYSE:WMT, ETR:WMT) shares slipped 2.5% in early trading on Friday after the retail giant disclosed that its CEO Doug McMillon is retiring early in 2026 after leading the company for nearly 12 years. McMillon will be succeeded by John Furner, who is currently the CEO of Walmart US, on February 1, 2026.